← The Wire
IMCRNasdaq
Immunocore Holdings plc
Biological Products, (No Diagnostic Substances) · X0 · CIK 1671927
Immunocore Holdings plc develops and commercializes T-cell receptor-based therapies
$1.47B
Market cap
$30.42
Last close
-1.5%
1D
+3.6%
5D
502K
Volume
Price · last 39 sessions+6.7%
May 4L $27.79 · H $30.88Jun 29
102
Total filings
May 27, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 27, 20268-KResults of OperationsMay 6, 202610-Q10-QMay 6, 2026DEF 14ADEF 14AApr 16, 20268-KResults of OperationsFeb 25, 202610-K10-KFeb 25, 20268-KExecutive ChangeJan 30, 20268-KResults of Operations · Reg FD DisclosureJan 9, 20268-KExecutive ChangeNov 28, 20258-KResults of OperationsNov 6, 202510-Q10-QNov 6, 20258-KResults of OperationsAug 7, 202510-Q10-QAug 7, 20258-KShareholder VoteMay 15, 20258-KResults of OperationsMay 7, 202510-Q10-QMay 7, 2025DEF 14ADEF 14AApr 4, 20258-KCompany UpdateMar 17, 20258-KReg FD DisclosureMar 10, 20258-KExecutive Change · Results of OperationsFeb 26, 202510-K10-KFeb 26, 20258-KResults of Operations · Reg FD DisclosureJan 10, 20258-KExecutive Change · Reg FD DisclosureJan 2, 20258-KAgreement TerminatedNov 8, 20248-KResults of OperationsNov 6, 202410-Q10-QNov 6, 20248-KCompany UpdateSep 16, 2024SC 13GSC 13GSep 10, 20248-KExecutive Change · Reg FD DisclosureAug 29, 20248-KResults of OperationsAug 8, 202410-Q10-QAug 8, 20248-KReg FD DisclosureMay 31, 20248-KCompany UpdateMay 30, 20248-KExecutive Change · Material AgreementMay 28, 20248-KShareholder VoteMay 23, 20248-KResults of OperationsMay 8, 202410-Q10-QMay 8, 2024DEF 14ADEF 14AApr 12, 20248-KCompany UpdateApr 5, 2024SC 13GSC 13GMar 11, 20248-KResults of Operations · Reg FD DisclosureFeb 28, 202410-K10-KFeb 28, 2024SC 13GSC 13GFeb 14, 2024SC 13GSEC SCHEDULE 13GFeb 8, 20248-KMaterial Agreement · New Debt / ObligationFeb 2, 20248-KResults of Operations · Company UpdateJan 29, 20248-KResults of Operations · Reg FD DisclosureJan 5, 20248-KReg FD DisclosureJan 2, 20246-K6-KNov 7, 20236-K6-KAug 10, 20236-K6-KJul 14, 20236-K6-KJun 5, 20236-K6-KMay 16, 20236-K6-KMay 10, 20236-K6-KApr 18, 20236-K6-KApr 18, 20236-K6-KMar 10, 20236-K6-KMar 2, 202320-F20-FMar 1, 20236-K6-KMar 1, 20236-K6-KFeb 22, 2023SC 13GIMMUNOCORE HOLDINGS PLCFeb 14, 20236-K6-KJan 11, 20236-K6-KJan 9, 20236-K6-KDec 8, 20226-K6-KDec 2, 20226-K6-KNov 14, 20226-K6-KNov 9, 20226-K6-KSep 30, 20226-K6-KSep 9, 2022424B5424B5Sep 9, 20226-K6-KSep 9, 20226-K6-KAug 10, 2022SC 13DSCHEDULE 13DJul 21, 20226-K6-KJul 20, 20226-K6-KJul 11, 20226-K6-KJun 27, 20226-K6-KJun 9, 20226-K6-KJun 8, 20226-K6-KJun 6, 2022
Insider Activity
In the 90 days to Feb 18, 2026: 4 sold $5.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Jallal BahijaCHIEF EXECUTIVE OFFICER | Sell | 11,474 | $32.35 | $371K |
| Feb 18, 2026 | Berman David MHEAD OF R&D | Sell | 5,965 | $32.35 | $193K |
| Feb 18, 2026 | St Leger Tina AmberCHIEF HR OFFICER | Sell | 1,000 | $32.35 | $32K |
| Feb 18, 2026 | Goll JohnSVP, FINANCE & CAO | Sell | 698 | $32.35 | $23K |
| Dec 5, 2025 | Berman David MHEAD OF R&D | Sell | 572 | $40.14 | $23K |
| Dec 4, 2025 | Berman David MHEAD OF R&D | Sell | 31,341 | $40.26 | $1.3M |
| Nov 28, 2025 | Berman David MHEAD OF R&D | Sell | 5,521 | $40.09 | $221K |
| Nov 26, 2025 | Berman David MHEAD OF R&D | Sell | 69,404 | $40.12 | $2.8M |
| Nov 25, 2025 | Berman David MHEAD OF R&D | Sell | 18,020 | $40.03 | $721K |
| Nov 24, 2025 | Berman David MHEAD OF R&D | Sell | 100 | $40.00 | $4K |
| Sep 30, 2025 | Berman David MHEAD OF R&D | Sell | 61,849 | $35.23 | $2.2M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance